with section 524 of the Tariff Act of 1930 (19 
U.S.C. 1524), be deposited in the Customs 
User Fee Account and shall be used to directly 
reimburse each appropriation for the amount 
paid out of that appropriation for the costs in-
curred in providing services to international 
mail facilities. Amounts deposited in accordance 
with the preceding sentence shall be available 
until expended for the provision of customs 
services to international mail facilities. 
‘‘(ii) Notwithstanding section 524 of the 
Tariff Act of 1930 (19 U.S.C. 1524), 50 per-
cent of the amount of payments received under 
this paragraph shall be paid to the Secretary of 
the Treasury, which is in lieu of the payment 
of fees under paragraph (10).’’. 
(2) 
TECHNICAL
AMENDMENTS.—Paragraph 
(10) of section 13031(a) of the Consolidated Omni-
bus Budget Reconciliation Act of 1985 (19 U.S.C. 
58c(a)(10)) is amended— 
(A) by striking ‘‘or’’ in subparagraph (B); 
(B) by striking the period at the end of 
subparagraph (C)(iii) and inserting a comma 
and ‘‘or’’; 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(C) 
by 
inserting 
after 
subparagraph 
(C)(iii) the following: 
‘‘(D) an international mail facility.’’; and 
(D) in the undesignated material at the 
end by striking the period and inserting ‘‘or re-
ferred to in subparagraph (D) see paragraph 
(6).’’. 
(e) MANDATORY ADVANCED ELECTRONIC INFORMA-
TION FOR POSTAL SHIPMENTS.—Subparagraph (K) of 
section 343(a)(3) of the Trade Act of 2002 (Public Law 
107–210; 19 U.S.C. 2071 note) is amended to read as 
follows: 
‘‘(K) The Secretary shall require the Post-
master General to transmit or to ensure the 
transmission of the information required in 
paragraphs (1) and (2) to U.S. Customs and 
Border Protection for all shipments by the 
United States Postal Service which includes 
shipments that the United States Postal Service 
receives from foreign postal operators (ship-
ments from foreign postal operators may be 
transported by private carriers). All regulations 
issued pursuant to this provision are required 
to impose the same information requirements 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
on the United States Postal Service and private 
carriers.’’. 
(f) MANIFEST PENALTIES APPLIED TO THE UNITED 
STATES POSTAL SERVICE.— 
(1) PENALTIES FOR VIOLATIONS OF THE AR-
RIVAL, REPORTING, ENTRY, AND
CLEARANCE
RE-
QUIREMENTS.—Section 436 of the Tariff Act of 
1930 (19 U.S.C. 1436) is amended by adding at the 
end the following new subsection: 
‘‘(e) CIVIL PENALTIES ARISING FROM VIOLATIONS 
FOR POSTAL SHIPMENTS.—With respect to civil penalties 
provided for in subsections (b) and (d), the Postmaster 
General shall be liable for the penalty if the violation was 
caused by a foreign postal operator or the United States 
Postal Service.’’. 
(2) PENALTIES
FOR
FALSITY
OR
LACK
OF 
MANIFEST.—Section 584 of the Tariff Act of 1930 
(19 U.S.C. 1584) is amended by adding at the end 
the following new subsection: 
‘‘(c) PERSON DIRECTLY OR INDIRECTLY RESPON-
SIBLE SHALL INCLUDE THE POSTMASTER GENERAL.— 
For purposes of subsection (a), the Postmaster General 
may be the person directly or indirectly responsible for a 
discrepancy if the discrepancy is the result of— 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
‘‘(1) an omission by a foreign postal operator or 
the United States Postal Service; or 
‘‘(2) false information regarding the shipment 
that was provided to the carrier by a foreign postal 
operator or the United States Postal Service.’’. 
(g) LIMITATION ON INTERNATIONAL POSTAL AR-
RANGEMENTS.— 
(1) EXISTING AGREEMENTS.— 
(A) IN GENERAL.—In the event that any 
provision in this section is found to be in viola-
tion of obligations of the United States under 
the Universal Postal Union, the Secretary of 
State shall negotiate to amend the relevant pro-
visions of the agreement so that the United 
States is no longer in violation of the agree-
ment. 
(B) CONSTRUCTION.—Nothing in this sub-
section may be construed to require or permit 
any delay in the implementation of this section. 
(2) FUTURE AGREEMENTS.—The Secretary of 
State may not conclude any international postal ar-
rangement pursuant to the authority set out in sec-
tion 407 of title 39, United States Code, that is in-
consistent with this section or any amendment made 
by this section. 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(h) APPLICATION OF OTHER CUSTOMS LAWS.— 
(1) IN GENERAL.—U.S. Customs and Border 
Protection shall ensure that all merchandise, as that 
term is defined in subsection (c) of section 498 of 
the Tariff Act of 1930 (19 U.S.C. 1498), imported 
to the United States through the mail shall be sub-
ject to the same import procedures, legal restric-
tions, and certifications as merchandise imported by 
private carriers. 
(2) REGULATIONS.—The Secretary of the 
Treasury shall issue regulations pursuant to this 
section to ensure that merchandise imported through 
the mail is in accordance with Federal law. 
(i) COST RECOUPMENT.—The Postmaster General 
shall ensure that all costs associated with complying with 
this section, as well as all penalties assessed against the 
Postmaster General, are charged directly to foreign ship-
pers, foreign postal operators, or United States ultimate 
consignees. 
(j) EFFECTIVE DATE; REGULATIONS.— 
(1) EFFECTIVE DATE.—This section shall be-
come effective upon the date of the enactment of 
this Act. 
(2) REGULATIONS.—Not later than 1 year after 
the date of the enactment of this Act, the Secretary 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
shall prescribe all regulations required under this 
section. 
SEC. 8. STOP THE IMPORTATION AND TRAFFICKING OF 
SYNTHETIC ANALOGUES. 
(a) ESTABLISHMENT OF SCHEDULE A.—Section 202 
of the Controlled Substances Act (21 U.S.C. 812) is 
amended— 
(1) in subsection (a), by striking ‘‘five schedules 
of controlled substances, to be known as schedules I, 
II, III, IV, and V’’ and inserting ‘‘six schedules of 
controlled substances, to be known as schedules I, 
II, III, IV, V, and A’’; 
(2) in subsection (b), by adding at the end the 
following: 
‘‘(6) SCHEDULE A.— 
‘‘(A) IN GENERAL.—The drug or substance— 
‘‘(i) has— 
‘‘(I) a chemical structure that is sub-
stantially similar to the chemical structure 
of a controlled substance in schedule I, II, 
III, IV, or V; and 
‘‘(II) an actual or predicted stimulant, 
depressant, or hallucinogenic effect on the 
central nervous system that is substantially 
similar to or greater than the stimulant, 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
depressant, or hallucinogenic effect on the 
central nervous system of a controlled sub-
stance in schedule I, II, III, IV, or V; and 
‘‘(ii) is not— 
‘‘(I) listed or otherwise included in 
any other schedule in this section or by 
regulation of the Attorney General; and 
‘‘(II) with respect to a particular per-
son, subject to an exemption that is in ef-
fect for investigational use, for that person, 
under section 505 of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 355) 
to the extent conduct with respect to such 
substance is pursuant to such exemption. 
‘‘(B) PREDICTED STIMULANT, DEPRESSANT, OR 
HALLUCINOGENIC
EFFECT.—For purpose of this 
paragraph, a predicted stimulant, depressant, or hal-
lucinogenic effect on the central nervous system may 
be based on— 
‘‘(i) the chemical structure, structure activ-
ity relationships, binding receptor assays, or 
other relevant scientific information about the 
substance; 
‘‘(ii)(I) the current or relative potential for 
abuse of the substance; and 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
‘‘(II) the clandestine importation, manu-
facture, or distribution, or diversion from legiti-
mate channels, of the substance; or 
‘‘(iii) the capacity of the substance to 
cause a state of dependence, including physical 
or psychological dependence that is similar to or 
greater than that of a controlled substance in 
schedule I, II, III, IV, or V.’’; and 
(3) in subsection (c)— 
(A) in the matter preceding schedule I, by 
striking ‘‘IV, and V’’ and inserting ‘‘IV, V, and 
A’’; and 
(B) by adding at the end the following: 
‘‘SCHEDULE A 
‘‘(a) Unless specifically excepted or unless listed in 
another schedule, any of the following substances, as 
scheduled in accordance with section 201(k)(5): 
‘‘(1) 4-fluoroisobutyryl fentanyl. 
‘‘(2) Valeryl fentanyl. 
‘‘(3) 4-methoxybutyryl fentanyl. 
‘‘(4) 4-methylphenethyl acetyl fentanyl. 
‘‘(5) 3-furanyl fentanyl. 
‘‘(6) Ortho-fluorofentanyl. 
‘‘(7) Tetrahydrofuranyl fentanyl. 
‘‘(8) Ocfentanil. 
‘‘(9) 4-fluorobutyryl fentanyl. 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
‘‘(10) Methoxyacetyl fentanyl. 
‘‘(11) Meta-fluorofentanyl. 
‘‘(12) Isobutyryl fentanyl. 
‘‘(13) Acryl fentanyl.’’. 
(b) TEMPORARY AND PERMANENT SCHEDULING OF 
SCHEDULE A SUBSTANCES.—Section 201 of the Con-
trolled Substances Act (21 U.S.C. 811) is amended by 
adding at the end the following: 
‘‘(k) TEMPORARY AND PERMANENT SCHEDULING OF 
SCHEDULE A SUBSTANCES.— 
‘‘(1) The Attorney General may issue a tem-
porary order adding a drug or substance to schedule 
A if the Attorney General finds that— 
‘‘(A) the drug or other substance satisfies 
the criteria for being considered a schedule A 
substance; and 
‘‘(B) adding such drug or substance to 
schedule A will assist in preventing abuse or 
misuse of the drug or other substance. 
‘‘(2) A temporary scheduling order issued under 
paragraph (1) shall not take effect until 30 days 
after the date of the publication by the Attorney 
General of a notice in the Federal Register of the in-
tention to issue such order and the grounds upon 
which such order is to be issued. The temporary 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
scheduling order shall expire not later than 5 years 
after the date it becomes effective, except that the 
Attorney General may, during the pendency of pro-
ceedings under paragraph (5), extend the temporary 
scheduling order for up to 180 days. 
‘‘(3) A temporary scheduling order issued under 
paragraph (1) shall be vacated upon the issuance of 
a permanent order issued under paragraph (5) with 
regard to the same substance, or upon the subse-
quent issuance of any scheduling order under this 
section. 
‘‘(4) A temporary scheduling order issued under 
paragraph (1) shall not be subject to judicial review. 
‘‘(5) The Attorney General may, by rule, issue 
a permanent order adding a drug or other substance 
to schedule A if such drug or substance satisfies the 
criteria for being considered a schedule A substance. 
Such rulemaking may be commenced simultaneously 
with the issuance of the temporary scheduling order 
issued under paragraph (1) with regard to the same 
substance. 
‘‘(6) Before initiating proceedings under para-
graph (1) or (5), the Attorney General shall trans-
mit notice of an order proposed to be issued to the 
Secretary of Health and Human Services. In issuing 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
an order under paragraph (1) or (5), the Attorney 
General shall take into consideration any comments 
submitted by the Secretary of Health and Human 
Services in response to a notice transmitted pursu-
ant to this paragraph. 
‘‘(7) On the date of the publication of a notice 
in the Federal Register pursuant to paragraph (2), 
the Attorney General shall transmit the same notice 
to Congress. The temporary scheduling order shall 
take effect according to paragraph (2), except that 
the temporary scheduling order may be disapproved 
by Act of Congress within 180 days from the date 
of publication of the notice in the Federal Reg-
ister.’’. 
(c) PENALTIES.— 
(1) CONTROLLED SUBSTANCES ACT.—The Con-
trolled Substances Act (21 U.S.C. 801 et seq.) is 
amended— 
(A) in section 401(b)(1) (21 U.S.C. 
841(b)(1)), by adding at the end the following: 
‘‘(F)(i) In the case of any controlled substance in 
schedule A, such person shall be sentenced to a term of 
imprisonment of not more than 10 years and if death or 
serious bodily injury results from the use of such sub-
stance shall be sentenced to a term of imprisonment of 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
stance shall be sentenced to a term of imprisonment of 
not more than life, a fine not to exceed the greater of that 
authorized in accordance with the provisions of title 18, 
United States Code, or $1,000,000 if the defendant is an 
individual or $5,000,000 if the defendant is other than 
an individual, or both. If any person commits such a viola-
tion after a prior conviction for a felony drug offense has 
become final, such person shall be sentenced to a term 
of imprisonment of not more than 30 years and if death 
or serious bodily injury results from the use of such sub-
stance shall be sentenced to not more than life imprison-
ment, a fine not to exceed the greater of twice that author-
ized in accordance with the provisions of title 18, United 
States Code, or $2,000,000 if the defendant is an indi-
vidual or $10,000,000 if the defendant is other than an 
individual, or both. Notwithstanding section 3583 of title 
18, United States Code, any sentence imposing a term of 
imprisonment under this paragraph shall, in the absence 
of such a prior conviction, impose a term of supervised 
release of not less than 3 years in addition to such term 
of imprisonment and shall, if there was such a prior con-
viction, impose a term of supervised release of not less 
than 6 years in addition to such term of imprisonment. 
Notwithstanding the prior sentence, and notwithstanding 
any other provision of law, the court shall not place on 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00049
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
probation or suspend the sentence of any person sentenced 
under the provisions of this paragraph which provide for 
a mandatory term of imprisonment if death or serious 
bodily injury results.’’. 
(d) FALSE LABELING OF SCHEDULE A CONTROLLED 
SUBSTANCES.— 
(1) IN
GENERAL.—Section 305 of the Con-
trolled Substances Act (21 U.S.C. 825) is amended 
by adding at the end the following: 
‘‘(f) FALSE
LABELING
OF
SCHEDULE
A CON-
TROLLED SUBSTANCES.— 
‘‘(1) It shall be unlawful to import, export, 
manufacture, distribute, dispense, or possess with 
intent to manufacture, distribute, or dispense, a 
schedule A substance or product containing a sched-
ule A substance, unless the substance or product 
bears a label clearly identifying a schedule A sub-
stance or product containing a schedule A substance 
by the nomenclature used by the International 
Union of Pure and Applied Chemistry (IUPAC). 
‘‘(2)(A) A product described in subparagraph 
(B) is exempt from the International Union of Pure 
and Applied Chemistry nomenclature requirement of 
this subsection if such product is labeled in the man-
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00050
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
ner required under the Federal Food, Drug, and 
Cosmetic Act. 
‘‘(B) A product is described in this subpara-
graph if the product— 
‘‘(i) is the subject of an approved applica-
tion as described in section 505(b) or (j) of the 
Federal Food, Drug, and Cosmetic Act; or 
‘‘(ii) is exempt from the provisions of sec-
tion 505 of such Act relating to new drugs be-
cause— 
‘‘(I) it is intended solely for investiga-
tional use as described in section 505(i) of 
such Act; and 
‘‘(II) such product is being used ex-
clusively for purposes of a clinical trial 
that is the subject of an effective investiga-
tional new drug application.’’. 
(2) PENALTIES.—Section 402 of the Controlled 
Substances Act (21 U.S.C. 842) is amended— 
(A) in subsection (a)(16), by inserting ‘‘or 
subsection (f)’’ after ‘‘subsection (e)’’; and 
(B) in subsection (c)(1)(D), by inserting 
‘‘or a schedule A substance’’ after ‘‘anabolic 
steroid’’. 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00051
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(e) REGISTRATION REQUIREMENTS FOR HANDLERS 
OF SCHEDULE A SUBSTANCES.— 
(1) CONTROLLED
SUBSTANCES
ACT.—Section 
303 of the Controlled Substances Act (21 U.S.C. 
823) is amended by adding at the end the following: 
‘‘(k)(1) The Attorney General shall register an appli-
cant to manufacture schedule A substances if— 
‘‘(A) the applicant demonstrates that the sched-
ule A substances will be used for research, analyt-
ical, or industrial purposes approved by the Attorney 
General; and 
‘‘(B) the Attorney General determines that such 
registration is consistent with the public interest and 
with the United States obligations under inter-
national treaties, conventions, or protocols in effect 
on the date of enactment of this subsection. 
‘‘(2) In determining the public interest under para-
graph (1)(B), the Attorney General shall consider— 
‘‘(A) maintenance of effective controls against 
diversion of particular controlled substances and any 
controlled substance in schedule A compounded 
therefrom into other than legitimate medical, sci-
entific, research, or industrial channels, by limiting 
the importation and bulk manufacture of such con-
trolled substances to a number of establishments 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00052
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
which can produce an adequate and uninterrupted 
supply of these substances under adequately com-
petitive conditions for legitimate medical, scientific, 
research, and industrial purposes; 
‘‘(B) compliance with applicable State and local 
law; 
‘‘(C) promotion of technical advances in the art 
of manufacturing substances described in subpara-
graph (A) and the development of new substances; 
‘‘(D) prior conviction record of applicant under 
Federal and State laws relating to the manufacture, 
distribution, or dispensing of substances described in 
paragraph (A); 
‘‘(E) past experience in the manufacture of con-
trolled substances, and the existence in the establish-
ment of effective control against diversion; and 
‘‘(F) such other factors as may be relevant to 
and consistent with the public health and safety. 
‘‘(3) If an applicant is registered to manufacture con-
trolled substances in schedule I or II under subsection (a), 
the applicant shall not be required to apply for a separate 
registration under this subsection. 
‘‘(l)(1) The Attorney General shall register an appli-
cant to distribute schedule A substances— 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00053
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
‘‘(A) if the applicant demonstrates that the 
schedule A substances will be used for research, ana-
lytical, or industrial purposes approved by the Attor-
ney General; and 
‘‘(B) unless the Attorney General determines 
that the issuance of such registration is inconsistent 
with the public interest. 
‘‘(2) In determining the public interest under para-
graph (1)(B), the Attorney General shall consider— 
‘‘(A) maintenance of effective control against 
diversion of particular controlled substances into 
other than legitimate medical, scientific, and indus-
trial channels; 
‘‘(B) compliance with applicable State and local 
law; 
‘‘(C) prior conviction record of applicant under 
Federal or State laws relating to the manufacture, 
distribution, or dispensing of substances described in 
subparagraph (A); 
‘‘(D) past experience in the distribution of con-
trolled substances; and 
‘‘(E) such other factors as may be relevant to 
and consistent with the public health and safety. 
‘‘(3) If an applicant is registered to distribute a con-
trolled substance in schedule I or II under subsection (b), 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00054
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
the applicant shall not be required to apply for a separate 
registration under this subsection. 
‘‘(m)(1) Not later than 90 days after the date on 
which a substance is placed in schedule A, any practitioner 
who was engaged in research on the substance before the 
placement of the substance in schedule A and any manu-
facturer or distributor who was handling the substance be-
fore the placement of the substance in schedule A shall 
register with the Attorney General. 
‘‘(2)(A) Not later than 60 days after the date on 
which the Attorney General receives an application for 
registration to conduct research on a schedule A sub-
stance, the Attorney General shall— 
‘‘(i) grant, or initiate proceedings under section 
304(c) to deny, the application; or 
‘‘(ii) request supplemental information from the 
applicant. 
‘‘(B) Not later than 30 days after the date on which 
the Attorney General receives supplemental information 
requested under subparagraph (A)(ii) in connection with 
an application described in subparagraph (A), the Attor-
ney General shall grant or deny the application. 
‘‘(n)(1) The Attorney General shall register a sci-
entific investigator or a qualified research institution to 
conduct research with controlled substances in schedule A 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00055
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
General determines that the registration modification 
would be inconsistent with the public interest based on the 
criteria of subsection (f). 
‘‘(4) Registrations issued under this subsection to a 
qualified research institution will apply to all agents and 
employees of that institution acting within the scope of 
their professional practice. 
‘‘(5) At least thirty days prior to conducting any re-
search with a controlled substance in schedule A, the reg-
istrant shall provide the Attorney General with written no-
tification of the following: 
‘‘(A) The name of and drug code for each sub-
stance. 
‘‘(B) The name of each individual with access 
to each substance. 
‘‘(C) The amount of each substance. 
‘‘(D) Other similar information the Attorney 
General may require. 
‘‘(6) The quantity of a schedule A controlled sub-
stance possessed by a person registered under this sub-
section shall be appropriate for the research being con-
ducted, subject to the additional limitations set forth in 
this paragraph. To reduce the risk of diversion, the Attor-
ney General may establish limitations on the quantity of 
schedule A controlled substances that may be manufac-
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00057
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
tured or possessed for purposes of research under this sub-
section and shall publish such limitations on the website 
of the Drug Enforcement Administration. A person reg-
istered under this subsection may, based on legitimate re-
search needs, apply to the Attorney General to manufac-
ture or possess an amount greater than that so specified 
by the Attorney General. The Attorney General shall 
specify the manner in which such applications shall be 
submitted. The Attorney General shall act on an applica-
tion filed under this subparagraph within 30 days of re-
ceipt of such application. If the Attorney General fails to 
act within 30 days, the registrant shall be allowed to man-
ufacture and possess up to the amount requested. The At-
torney General shall have the authority to reverse the in-
crease for cause. 
‘‘(7) The Attorney General shall by regulation specify 
the manner in which applications for registration under 
this subsection shall be submitted. 
‘‘(8) Registrants authorized under this subsection 
may manufacture and possess schedule A controlled sub-
stances up to the approved amounts only for use in their 
own research setting or institution. Manufacturing for use 
in any other setting or institution shall require a manufac-
turer’s registration under section 303(a).’’. 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00058
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(2) CONTROLLED
SUBSTANCES
IMPORT
AND 
EXPORT ACT.—Section 1008 of the Controlled Sub-
stances Import and Export Act (21 U.S.C. 958) is 
amended by adding at the end the following: 
‘‘(j)(1) The Attorney General shall register an appli-
cant to import or export a schedule A substance if— 
‘‘(A) the applicant demonstrates that the sched-
ule A substances will be used for research, analyt-
ical, or industrial purposes approved by the Attorney 
General; and 
‘‘(B) the Attorney General determines that such 
registration is consistent with the public interest and 
with the United States obligations under inter-
national treaties, conventions, or protocols in effect 
on the date of enactment of this subsection. 
‘‘(2) In determining the public interest under para-
graph (1)(B), the Attorney General shall consider the fac-
tors described in subparagraphs (A) through (F) of sec-
tion 303(k)(2). 
‘‘(3) If an applicant is registered to import or export 
a controlled substance in schedule I or II under subsection 
(a), the applicant shall not be required to apply for a sepa-
rate registration under this subsection.’’. 
(f) ADDITIONAL CONFORMING AMENDMENTS.— 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00059
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(1) CONTROLLED SUBSTANCES ACT.—The Con-
trolled Substances Act (21 U.S.C. 801 et seq.) is 
amended— 
(A) in section 303(c) (21 U.S.C. 823(c))— 
(i) by striking ‘‘subsections (a) and 
(b)’’ and inserting ‘‘subsection (a), (b), (k), 
or (l)’’; and 
(ii) by striking ‘‘schedule I or II’’ and 
inserting ‘‘schedule I, II, or A’’; 
(B) in section 306 (21 U.S.C. 826)— 
(i) in subsection (a), in the first sen-
tence, by striking ‘‘schedules I and II’’ and 
inserting ‘‘schedules I, II, and A’’; 
(ii) in subsection (b), in the second 
sentence, by striking ‘‘schedule I or II’’ 
and inserting ‘‘schedule I, II, or A’’; 
(iii) in subsection (c), in the first sen-
tence, by striking ‘‘schedules I and II’’ and 
inserting ‘‘schedules I, II, and A’’; 
(iv) in subsection (d), in the first sen-
tence, by striking ‘‘schedule I or II’’ and 
inserting ‘‘schedule I, II, or A’’; 
(v) in subsection (e), in the first sen-
tence, by striking ‘‘schedule I or II’’ and 
inserting ‘‘schedule I, II, or A’’; and 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00060
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS
(vi) in subsection (f), in the first sen-
tence, by striking ‘‘schedules I and II’’ and 
inserting ‘‘schedules I, II, and A’’; 
(C) in section 308(a) (21 U.S.C. 828(a)), 
by striking ‘‘schedule I or II’’ and inserting 
‘‘schedule I, II, or A’’; 
(D) in section 402(b) (21 U.S.C. 842(b)), 
in the matter preceding paragraph (1), by strik-
ing ‘‘schedule I or II’’ and inserting ‘‘schedule 
I, II, or A’’; 
(E) in section 403(a)(1) (21 U.S.C. 
843(a)(1)), by striking ‘‘schedule I or II’’ and 
inserting ‘‘schedule I, II, or A’’; and 
(F) in section 511(f) (21 U.S.C. 881(f)), 
by striking ‘‘schedule I or II’’ each place it ap-
pears and inserting ‘‘schedule I, II, or A’’. 
(2) CONTROLLED SUBSTANCES IMPORT EXPORT 
ACT.—The Controlled Substances Import and Ex-
port Act (21 U.S.C. 951 et seq.) is amended— 
(A) 
in 
section 
1002(a) 
(21 
U.S.C. 
952(a))— 
(i) in the matter preceding paragraph 
(1), by striking ‘‘schedule I or II’’ and in-
serting ‘‘schedule I, II, or A’’; and 
VerDate Sep 11 2014 
03:13 Apr 20, 2018
Jkt 079200
PO 00000
Frm 00061
Fmt 6652
Sfmt 6201
E:\BILLS\H5531.IH
H5531
SSpencer on DSKBBXCHB2PROD with BILLS